Arcadia Biosciences, Inc., an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits. It also provides nutritional oils comprising gamma linolenic acid safflower oil to manufacturers of dietary and nutritional supplements, medical foods, dog food, and other products under the SONOVA brand; and arachidonic acid safflower oil that is used as an ingredient in infant nutrition products. In addition, the company has various programs under development comprising fiber resistant starch wheat, whole grain flour, and reduced gluten wheat programs. Arcadia Biosciences, Inc. has strategic collaborations with Dow AgroSciences and Ardent Mills LLC to develop and commercialize wheat varieties. The company was founded in 2002 and is headquartered in Davis, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Agricultural chemicals
Sub-IndustryN/A
SectorBasic Materials
Current SymbolNASDAQ:RKDA
Previous Symbol
CUSIPN/A
Phone530-756-7077
Debt
Debt-to-Equity RatioN/A
Current Ratio9.96
Quick Ratio9.83
Price-To-Earnings
Trailing P/E Ratio-0.55
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$4.03 million
Price / Sales4.50
Cash FlowN/A
Price / Cash FlowN/A
Book Value$3.75 per share
Price / Book1.01
Profitability
EPS (Most Recent Fiscal Year)($6.86)
Net Income$-15,700,000.00
Net Margins-645.18%
Return on Equity-302.21%
Return on Assets-92.09%
Miscellaneous
Employees42
Outstanding Shares4,770,000
Market Cap$21.34 million
OptionableNot Optionable
Arcadia Biosciences (NASDAQ:RKDA) Frequently Asked Questions
What is Arcadia Biosciences' stock symbol?
Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."
When did Arcadia Biosciences' stock split? How did Arcadia Biosciences' stock split work?
Arcadia Biosciences's stock reverse split on the morning of Wednesday, January 24th 2018. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 23rd 2018. An investor that had 100 shares of Arcadia Biosciences stock prior to the reverse split would have 5 shares after the split.
How were Arcadia Biosciences' earnings last quarter?
Arcadia Biosciences Inc (NASDAQ:RKDA) released its quarterly earnings results on Wednesday, November, 7th. The basic materials company reported $0.93 earnings per share for the quarter, beating the Zacks' consensus estimate of ($1.13) by $2.06. The basic materials company earned $0.37 million during the quarter, compared to the consensus estimate of $0.26 million. Arcadia Biosciences had a negative return on equity of 302.21% and a negative net margin of 645.18%. View Arcadia Biosciences' Earnings History.
When is Arcadia Biosciences' next earnings date?
What price target have analysts set for RKDA?
2 brokerages have issued twelve-month price objectives for Arcadia Biosciences' shares. Their forecasts range from $20.00 to $20.00. On average, they expect Arcadia Biosciences' share price to reach $20.00 in the next twelve months. This suggests a possible upside of 426.3% from the stock's current price. View Analyst Price Targets for Arcadia Biosciences.
What is the consensus analysts' recommendation for Arcadia Biosciences?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Arcadia Biosciences.
What are Wall Street analysts saying about Arcadia Biosciences stock?
Here are some recent quotes from research analysts about Arcadia Biosciences stock:
- 1. According to Zacks Investment Research, "Arcadia Biosciences, Inc. is engaged in developing and commercializing agricultural products primarily in the United States. The Company's product includes nitrogen use crops, salt tolerant plants, sunflower oil and shelf-life produce. Arcadia Biosciences, Inc. is headquartered in Davis, California. " (10/10/2018)
- 2. HC Wainwright analysts commented, "Valuation methodology, risks and uncertainties. Our valuation utilizes a discounted cash flow-based approach that derives a $130M value for RS Wheat, using a 15% discount rate, 30% tax rate and 10% manufacturing spend." (8/8/2018)
Has Arcadia Biosciences been receiving favorable news coverage?
News headlines about RKDA stock have trended somewhat negative recently, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Arcadia Biosciences earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned media stories about the basic materials company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
Who are some of Arcadia Biosciences' key competitors?
Some companies that are related to Arcadia Biosciences include Evogene (EVGN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET), SenesTech (SNES), Kiwa Bio-Tech Products Group (KWBT), Cavitation Technologies (CVAT), Eden Research (EDEN), Monsanto (MON), Nufarm (NUF), Syngenta (SYT), Terra Nitrogen (TNH) and Wynnstay Group (WYN).
Who are Arcadia Biosciences' key executives?
Arcadia Biosciences' management team includes the folowing people:
- Mr. Rajendra Ketkar, Pres, CEO & Director (Age 64)
- Mr. Matthew T. Plavan, CFO & Sec. (Age 54)
- Dr. Zhongjin Lu Ph.D., Director of Product Devel. (Age 52)
- Ms. Sarah Reiter, Chief Commercial Officer (Age 46)
When did Arcadia Biosciences IPO?
(RKDA) raised $66 million in an initial public offering (IPO) on Friday, May 15th 2015. The company issued 8,200,000 shares at a price of $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray served as the underwriters for the IPO.
Who are Arcadia Biosciences' major shareholders?
Arcadia Biosciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Virtu Financial LLC (0.52%), Dimensional Fund Advisors LP (0.48%) and Vanguard Group Inc (0.39%). Company insiders that own Arcadia Biosciences stock include Eric J Rey and Zhongjin Lu. View Institutional Ownership Trends for Arcadia Biosciences.
Which major investors are buying Arcadia Biosciences stock?
How do I buy shares of Arcadia Biosciences?
Shares of RKDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Arcadia Biosciences' stock price today?
One share of RKDA stock can currently be purchased for approximately $3.80.
How big of a company is Arcadia Biosciences?
Arcadia Biosciences has a market capitalization of $21.34 million and generates $4.03 million in revenue each year. The basic materials company earns $-15,700,000.00 in net income (profit) each year or ($6.86) on an earnings per share basis. Arcadia Biosciences employs 42 workers across the globe.
What is Arcadia Biosciences' official website?
How can I contact Arcadia Biosciences?
Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The basic materials company can be reached via phone at 530-756-7077 or via email at [email protected]
MarketBeat Community Rating for Arcadia Biosciences (NASDAQ RKDA)
MarketBeat's community ratings are surveys of what our community members think about Arcadia Biosciences and other stocks. Vote "Outperform" if you believe RKDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RKDA will underperform the S&P 500 over the long term. You may vote once every thirty days.
